INSYBIO

A disruptor to Precision Medicine and Nutrition through biomarker discovery InSyBio is a privately held Company focusing, through advanced big-data computational tools, on biomarker discovery for Cancer, Neurodegenerative diseases and Nutrition. Biomarker extraction from biological big data (genomics, transcriptomics, proteomics, etc.) is essential for drug discovery research acceleration, personalized medicine and personalized Nutrition. Modern approaches in... These advantages are enabled by InSyBio's proprietary technology which offers simultaneous integration of data from different sources and types and has demonstrated ability to locate significantly more common proteins in large scale proteomics datasets. InSyBio's solutions are based on biological networks modeling to integrate many layers of complex biological information (mutations, proteins, clinical variables, peptides etc.) and advanced big data-oriented artificial intelligence methods.

Also known as: InSyBio Group, InSyBio Inc., InSyBio Ltd., InSyBIo PC

Registration numbers: 134984416000 (W), 8715590 (W)

Primary location: Narragansett United States